Durata Therapeutics' (DRTX) Dalvance Receives FDA Approval as Skin Infection Treatment
Tweet Send to a Friend
(Updated - May 23, 2014 3:49 PM EDT)The FDA approves Durata Therapeutics' (NASDAQ: DRTX) Dalvance to treat skin infections.UPDATE - ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
